Business
– Acting CEO Eyal Desheh / Getty – Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) acting CEO Eyal Desheh today said that Copaxone continued to lead...
Hi, what are you looking for?
– Acting CEO Eyal Desheh / Getty – Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) acting CEO Eyal Desheh today said that Copaxone continued to lead...
– Third quarter EPS of $1.27 on revenue of $5.1 billion compares with a consensus estimate of $1.26 on revenue of $5 billion. – ...
– Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) is Israel’s largest and most successful public company. As such what it does, and how it thinks, become...
– The plant will increase production capacity in the country to two billion tablets and capsules a year. – – Teva Pharmaceutical Industries Ltd. (NYSE: TEVA;...
– Teva says it will shed 10% of its workforce by the end of 2014 and hundreds of employees in Israel will lose their...
– Credit Suisse sees Copaxone sales falling from $4 billion annually to $400, 000 in 2019 and predicts annual sales of over $1 billion...
– Teva sees the court preventing Mylan from launching its generic version of the Parkinson’s treatment before 2017. – – Teva Pharmaceutical Industries Ltd....
– The 3D printer company’s secondary offering is an opportunity to look at its remarkable stock market performance, and the people who benefit from...
– Opko Health will have the tenth highest market cap on the Tel Aviv 25 Index. – Phillip Frost / Getty – / By...
– The decision maintains exclusivity for Copaxone until May 24, 2014. – Copaxone/ source : dynamik3d.ca – On Friday, the US Court of Appeals for...